Biostax Corp (BTAX)

OTC Markets
Currency in USD
0.0002
0.0000(0.00%)
Closed·
BTAX Scorecard
Full Analysis
Stock generally trades with low price volatility
Trading near 52-week Low
Fair Value
Day's Range
0.00020.0002
52 wk Range
0.00020.1500
Key Statistics
Edit
Prev. Close
0.0002
Open
0.0002
Day's Range
0.0002-0.0002
52 wk Range
0.0002-0.15
Volume
-
Average Volume (3m)
648
1-Year Change
-99.6%
Book Value / Share
-0.06
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BTAX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Biostax Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Biostax Corp Company Profile

Biostax Corp. operates as a biopharmaceutical company that acquires, develops, and commercializes pharmaceutical and biotechnology products. Its lead investigational drug candidate Lodonal, an once-a-day immune system regulator for the management of human immunodeficiency virus and acquired immune deficiency syndrome (HIV/AIDS). Its programs also include Medtech asset, an early development stage program that uses blockchain and smart contracts to manage and secure prescriptions and electronic health records; JKB-122, an investigational small molecule, long-acting toll-like receptor 4 (TLR4) antagonist developed for autoimmune hepatitis, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH); and Low Dose Naltrexone, a compound formula that is purported to provide immune-modulating benefits that include cancer, pain, autoimmune, and anti-aging. The company also develops programs for the treatment of hyperphosphatemia. It has a licensing agreement with Cytocom Inc. The company was formerly known as Immune Therapeutics, Inc. and changed its name to Biostax Corp. in October 2023. Biostax Corp. is headquartered in Winter Park, Florida.

Compare BTAX to Peers and Sector

Metrics to compare
BTAX
Peers
Sector
Relationship
P/E Ratio
0.0x−4.6x−0.5x
PEG Ratio
0.000.000.00
Price/Book
0.0x2.2x2.6x
Price / LTM Sales
-16.1x3.2x
Upside (Analyst Target)
-150.1%45.4%
Fair Value Upside
Unlock9.2%6.9%Unlock

Earnings

Latest Release
Apr 11, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

BTAX Income Statement

FAQ

What Stock Exchange Does Biostax Trade On?

Biostax is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Biostax?

The stock symbol for Biostax is "BTAX."

What Is the Biostax Market Cap?

As of today, Biostax market cap is 17.26K.

What Is Biostax's Earnings Per Share (TTM)?

The Biostax EPS (TTM) is -0.02.

From a Technical Analysis Perspective, Is BTAX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Biostax Stock Split?

Biostax has split 5 times.

How Many Employees Does Biostax Have?

Biostax has 4 employees.

What is the current trading status of Biostax (BTAX)?

As of 13 Jul 2025, Biostax (BTAX) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.15.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.